0NES.LSE Oriola Oyj Series B

Healthcare Oil, Gas & Consumable Fuels London Exchange
0.9423 EUR
Close of Nov 3, 2026
0.7340 1.21
Market cap
EUR 171M
P/E
6.7x
P/B
-
ROE
-1.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0NES.LSE undervalued?

Graham number

The Graham number of Oriola Oyj Series B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Oriola Oyj Series B fundamental analysis

No fundamental analysis for Oriola Oyj Series B yet.

Oriola Oyj Series B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Oriola Oyj Series B

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs a…

Full company profile